2015Chinese Journal of Infection ControlRequires access

Research on diminishing scheme of cefaclor sustained release tablets in the treatment of recurrent urinary tract infection

Tang Guo-chua

Open publisher page 0 citations

Abstract

Objective To explore the efficacy and adverse reactions of diminishing scheme of cefaclor sustained release tablets in the treatment of recurrent urinary tract infection(RUTI).Methods 60 RUTI patients in a hospital were divided into treatment group(n=30)and control group(n=30),patients in treatment group were treated with diminishing scheme of cefaclor sustained release tablets,patients in control group were treated with diminishing scheme of levofloxacin tablets,clinical therapeutic efficacy and adverse reactions of two groups were observed.Results The curative rate in treatment group was higher than control group([80.00%,n=24]vs[53.33%,n=16])(χ2=4.80,P=0.028).The incidence of RUTI in treatment group was lower than control group([6.67%,n=2]vs[26.67%,n=8])(χ2=4.32,P=0.038).Incidence of adverse reactions in treatment group was lower than control group(16.67% vs 50.00%)(χ2=7.50,P=0.006).Conclusion The diminishing scheme of cefaclor sustained release tablets in the treatment of RUTI has good curative efficacy,low recurrence rate,fewer adverse reactions,and can be used for the treatment of recurrence of RUTI.

About this research paper

What this paper is about

Objective To explore the efficacy and adverse reactions of diminishing scheme of cefaclor sustained release tablets in the treatment of recurrent urinary tract infection(RUTI).Methods 60 RUTI patients in a hospital were divided into treatment group(n=30)and control group(n=30),patients in treatment group were treated with diminishing scheme of cefaclor sustained release tablets,patients in control group were treated with diminishing scheme of levofloxacin tablets,clinical therapeutic efficacy and adverse reactions of two groups were observed.Results The curative rate in treatment group was higher than control group([80.00%,n=24]vs[53.33%,n=16])(χ2=4.80,P=0.028).The incidence of RUTI in treatment group was lower than control group([6.67%,n=2]vs[26.67%,n=8])(χ2=4.32,P=0.038).Incidence of adverse reactions in treatment group was lower than control group(16.67% vs 50.00%)(χ2=7.50,P=0.006).Conclusion The diminishing scheme of cefaclor sustained release tablets in the treatment of RUTI has good curative efficacy,low recurrence rate,fewer adverse reactions,and can be used for the treatment of recurrence of RUTI.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the efficacy and adverse reactions of diminishing scheme of cefaclor sustained release tablets in the treatment of recurrent urinary tract infection(RUTI).Methods 60 RUTI patients in a hospital were divided into treatment group(n=30)and control group(n=30),patients in treatment group were treated with diminishing scheme of cefaclor sustained release tablets,patients in control group were treated with diminishing scheme of levofloxacin tablets,clinical therapeutic efficacy and adverse reactions of two groups were observed.Results The curative rate in treatment group was higher than control group([80.00%,n=24]vs[53.33%,n=16])(χ2=4.80,P=0.028).The incidence of RUTI in treatment group was lower than control group([6.67%,n=2]vs[26.67%,n=8])(χ2=4.32,P=0.038).Incidence of adverse reactions in treatment group was lower than control group(16.67% vs 50.00%)(χ2=7.50,P=0.006).Conclusion The diminishing scheme of cefaclor sustained release tablets in the treatment of RUTI has good curative efficacy,low recurrence rate,fewer adverse reactions,and can be used for the treatment of recurrence of RUTI.

Key concepts: Cefaclor, Medicine, Adverse effect, Urinary system, Incidence (geometry), Internal medicine, Clinical efficacy, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Research on diminishing scheme of cefaclor sustained release tablets in the treatment of recurrent urinary tract infection — Research Paper | ScholarLens